According to a new report published by Allied
Market Research, titled,"Brain
Monitoring Market by Product Type, Procedure, and Application: Global
Opportunity Analysis and Industry Forecast, 2018-2025,"The global brain monitoring market generated USD
3,850 million in 2017, and is projected to reach USD 6,595 million by 2025,
growing at a CAGR of 6.9% from 2018 to 2025. The electroencephalography devices
segment accounted for more than one-fifth of the total market share in 2017.
Brain monitoring is a neuro-diagnostics
device used to monitor and diagnose the brain abnormalities by exploring the
structure and function of the brain. These devices are used to monitor
neurological disorders such as Alzheimers, Parkinsons, epilepsy, dementia,
multiple sclerosis, sleep disorder, brain tumor, and others. Increase in
incidence of neurological disorders and rise in awareness of diseases boost the
demand for brain monitoring devices all across the world.
The global brain monitoring devices market
has witnessed an exceptional growth in the past few years. The increase in the
geriatric population and rise in prevalence of chronic diseases contribute
toward the market growth. In addition, advancements in technology is another
factor expected to boost the market growth during the forecast period. However,
stringent government regulations and unfavorable reimbursement policies are
projected to hamper the market growth during the forecast period. Conversely,
untapped markets in the developing countries are expected to offer remunerative
opportunities for the market players in the near future.
Based on product type, the market is
segmented into electroencephalography (EEG) devices, magnetoencephalography
(MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP)
monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized
tomography (CT) devices, positron emission tomography (PET) devices, sleep
monitoring devices, electromyography (EMG) devices, and accessories. The EEG
segment was the major revenue contributor in 2017, and is anticipated to
continue this trend during the forecast period, owing to the increase in demand
for diagnosis of critical disorders such as epilepsy. In addition, it has
further influenced companies to focus on the development of brain monitoring
EEG devices.
Depending on application, the market is
categorized into epilepsy, dementia, Parkinsons disease, Huntington's disease,
headache disorders, stroke, traumatic brain injuries, sleep disorders, and
other diseases. Patients suffering from Parkinsons disease need regular
checkups due to lack of treatment. This increases the demand for brain
monitoring devices.
North America is expected to remain dominant
throughout the forecast period attributable to its well-developed healthcare
industry, presence of leading manufacturers in the region, and high adoption
rate of brain monitoring devices. However, Asia-Pacific is expected to
experience the highest growth rate during the forecast period, due to increase
in number of geriatric population and rise in purchasing power of countries in
the region.
The report provides a comprehensive analysis
of the key players operating in the global brain monitoring market, namely,
Advanced Brain Monitoring, Inc., CAS Medical Systems, Inc., Compumedics Ltd.,
General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips
Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics,
Inc., and Siemens AG.
The other players in the value chain include
Cadwell Laboratories, Neurosoft Limited, Elekta A.B., InfraSacn, Inc., and
BrainScope Company, Inc., and others.
Key Findings of the Brain Monitoring Market:
Based on product type, the electromyography
devices segment is expected to experience rapid growth in the market, and is
projected to grow at a highest CAGR of 8.0% from 2018 to 2025.
Depending on procedure, the invasive segment
holds the highest share in 2017, and is anticipated to continue this trend
during the forecast period.
By application, the traumatic brain injuries
segment was the major revenue contributor in 2017, and is anticipated to continue
this trend during the forecast period.
U.S. generated the highest revenue in the
global brain monitoring market in 2017, accounting for more than two-fifths of
the global market in 2017.
LAMEA is estimated to grow at a CAGR of 8.9%
during the forecast period.
To know more, click on the link below:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91-9015378249
